EVAX Evaxion Biotech A/S

Nasdaq evaxion-biotech.com


$ 6.30 $ 0.22 (3.74 %)    

Monday, 27-Oct-2025 11:56:20 EDT
QQQ $ 626.40 $ 0.00 (0 %)
DIA $ 474.51 $ -0.28 (-0.06 %)
SPY $ 683.34 $ 0.57 (0.08 %)
TLT $ 91.47 $ 0.16 (0.18 %)
GLD $ 366.94 $ -4.16 (-1.12 %)
$ 5.89
$ 6.02
$ 6.29 x 53
$ 6.43 x 100
$ 5.99 - $ 6.40
$ 1.20 - $ 15.50
263,933
na
413.07M
$ 4.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evaxion-as-appoints-helen-tayton-martin-ceo-effective-nov-24

Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powe...

 lake-street-maintains-buy-on-evaxion-raises-price-target-to-11

Lake Street analyst Thomas Flaten maintains Evaxion (NASDAQ:EVAX) with a Buy and raises the price target from $6 to $11.

 hc-wainwright--co-reiterates-buy-on-evaxion-maintains-16-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion (NASDAQ:EVAX) with a Buy and maintains $16 price t...

 evaxion-as-reports-two-year-phase-2-data-showing-results-for-its-personalized-cancer-vaccine-evx-01-in-advanced-melanoma-study-showed-a-75-objective-response-rate-with-4-of-16-patients-achieving-complete-responses-and-92-maintaining-durable-responses-at-24-months-with-no-relapses

Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ power...

 evaxion-will-present-comprehensive-phase-2-trial-data-for-its-lead-cancer-vaccine-evx-01-at-the-esmo-congress-2025-in-berlin-oct-1721-2025

Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on ...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

 hc-wainwright--co-maintains-buy-on-evaxion-raises-price-target-to-16

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Evaxion (NASDAQ: EVAX) with a Buy and raises the price targ...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

Core News & Articles

OPEN: 11% | Opendoor shares are trading higher after Jane Street Group disclosed in a 13G filing that it holds a 5.9% stake in ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION